Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) rose 63% during mid-day trading on Thursday . The stock traded as high as $1.50 and last traded at $1.50. Approximately 39,500 shares changed hands during trading, an increase of 1,094% from the average daily volume of 3,307 shares. The stock had previously closed at $0.92.
Idorsia Price Performance
The company has a 50-day moving average price of $1.41 and a 200-day moving average price of $2.10.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Recommended Stories
- Five stocks we like better than Idorsia
- Compound Interest and Why It Matters When Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The Significance of Brokerage Rankings in Stock Selection
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What to Know About Investing in Penny Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
